New Zealand, New Zealand

Colin Roger Ogle


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Colin Roger Ogle: Innovator in Therapeutic Applications

Introduction

Colin Roger Ogle is a notable inventor based in New Zealand, recognized for his contributions to the field of therapeutic and prophylactic uses of specific combinations derived from milk. His innovative approach focuses on modulating the microbiome of animals, targeting pathogenic microorganisms effectively.

Latest Patents

Colin holds a patent for a unique invention titled "Combination, therapeutic uses and prophylactic uses." This invention relates to the therapeutic and prophylactic use of a combination that includes lactoperoxidase and at least one other component, which has an isoelectric point of, or substantially above 6.8. These components are extracted from milk and are designed to selectively modulate the microbiome of an animal against at least one pathogenic microorganism. He has 1 patent to his name.

Career Highlights

Colin is associated with Quantec Limited, where he applies his expertise in developing innovative solutions in the field of microbiome modulation. His work has significant implications for animal health and wellness, showcasing his commitment to advancing therapeutic applications.

Collaborations

Colin collaborates with esteemed colleagues, including Judith Mary Bragger and Rodney Wayne Claycomb, who contribute to his research and development efforts. Their combined expertise enhances the potential impact of their innovations in the industry.

Conclusion

Colin Roger Ogle stands out as an inventor dedicated to improving animal health through innovative therapeutic solutions. His work exemplifies the intersection of science and practical application, making a meaningful contribution to the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…